Most Recent Funding
$300 Thousand Debt Financing on December 21, 2011
Headquarters:
La Jolla, CA
Description:
Afraxis is focused on discovering and developing drugs to treat diseases of the central nervous system.
Website:
http://www.afraxis.com

Detailed Description

Update

Afraxis is discovering and developing drugs to treat diseases of the central nervous system, including schizophrenia, Alzheimer's disease, Fragile X syndrome and autism spectrum disorders. Recent scientific discoveries have linked these disorders to underlying defects in the development and function of specialized structures of the neural synapse, called dendritic spines. Afraxis is leveraging this discovery to develop drug treatments that control dendritic spine function. The company's lead program targets PAK, a protein that regulates the development and activity of dendritic spines, creating therapies that actually modify the disease rather than just treat symptoms. Modifying the disease produces beneficial changes at the cellular and behavioral level, creating new hope for patients.

Current Team (2)

Update

Past Team (2)

Update

Funding Rounds (2) - $1.5M

Update

Offices/Locations (1)

Update
  • Office

    11099 N Torrey Pines Rd, Suite 290

    La Jolla, CA 92037

    USA

News (2)

Update